Related Experiment Video
Updated: Aug 9, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease
Rajan Sharma1, Denis Pellerin, David C Gaze
1Department of Cardiology, St George's Hospital, London, United Kingdom. rajdoc.Sharma@tiscali.co.uk
Insights
Mitral annular calcification (MAC) predicts mortality and cardiac disease in renal transplant candidates. Patients with MAC showed higher mortality, increased left ventricular size, and poorer systolic function.
Area of Science:
- Nephrology
- Cardiology
- Medical Imaging
Background:
- Mitral annular calcification (MAC) is a common finding in patients with end-stage renal disease (ESRD).
- The prognostic significance of MAC in renal transplant candidates is not well-established.
Purpose of the Study:
- To determine if mitral annular calcification (MAC) predicts mortality and cardiac disease in patients awaiting renal transplantation.
Main Methods:
- 140 renal transplant candidates underwent echocardiography and coronary angiography.
- Significant coronary artery disease (CAD) was defined as >70% stenosis in any major coronary artery.
Main Results:
- MAC was present in 40% of patients and associated with higher mortality (p=0.04).
- MAC patients were older, had larger left ventricular dimensions, reduced systolic function, and higher LV filling pressures.
- Significant CAD was the only independent predictor of MAC (OR 12, p=0.001).
- Higher levels of plasma calcium, phosphate, troponin T, and NT-proBNP were observed in patients with MAC.
Conclusions:
- Mitral annular calcification (MAC) is a significant predictor of mortality and coronary artery disease in ESRD patients.
- MAC is linked to adverse cardiac structural and functional changes, including increased left ventricular cavity size, impaired systolic function, and elevated filling pressures.
Background:
We sought to determine whether mitral annular calcification (MAC) predicts mortality and cardiac disease in a group of renal transplant candidates.
Methods:
Hundred and forty patients were prospectively studied. All had echocardiography and coronary angiography. Significant coronary artery disease (CAD) was defined as luminal stenosis >70% by visual estimation in at least one coronary artery.
Results:
There were 21 deaths over a follow-up period of 2.2+/-0.7 years. MAC occurred in 56 patients (40%) and was associated with higher mortality (p=0.04). Patients with MAC were older (p=or<0.001), had larger left ventricular (LV) end systolic (p=0.005) and LV end diastolic (p=0.04) diameter, larger left atrial diameter (p=0.001), lower LV fractional shortening (p=0.003), larger LV mass index (p=0.04) and higher mitral E/Ea ratio (p=0.03) compared to those without. Plasma calcium (p=0.002), phosphate (p=0.004), cardiac troponin T (p=0.03), N-terminal Pro-B-type natriuretic peptide (p=0.004) concentrations were higher in those with MAC but gender, total cholesterol, haemoglobin and creatinine were similar in the two groups. The proportion diabetic (p=0.03), on dialysis (p=0.05), with significant CAD (p=or<0.001), taking calcium containing phosphate binders (p=0.02) and Vitamin D3 (p=0.04) was significantly higher in those with MAC. Significant CAD (OR 12, 95% CI 3.25, p=0.001) was the only independent associate of MAC.
Conclusions:
MAC is associated with increased mortality and significant CAD in ESRD. These patients have increased LV cavity size, poorer LV systolic function, higher LV filling pressures compared to patients without MAC.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction

